1. Market Research
  2. > Therapy Industry

Immunotherapy Industry, January 2017 Market Reports from Top Publishers

You might be interested in: Therapy, Cancer, Oncology, Lung Cancer, Prostate Cancer, Respiratory Treatment, Targeted Therapy, Allergy Immunotherapy, Breast Cancer, Respiratory Disease, Brain Cancer, Colorectal Cancer, Dementia, Diabetes, Lymphoma, Pancreatic Cancer, Renal Cancer, Vaccine, Anti-Infective, Bladder Cancer.


 
1-10 of 81 reports for Immunotherapy

Purchase Reports From Reputable Market Research Publishers

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. In this report, ...

Allergic Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2016

Allergic Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • December 2016
  • by Global Data

Allergic Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Allergic Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2016" provides an overview ...

Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2016

Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • December 2016
  • by Global Data

Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2016" provides an overview of Rhino-Conjunctivitis ...

Cancer Immunotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Cancer Immunotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Global Cancer Immunotherapy Market: Overview The growing incidences of cancer and a need to treat them is the key driver of the global immunotherapy market. The number of deaths occurring due to cance ...

Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H2 2016

Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Cervical Intraepithelial Neoplasia (CIN) ...

Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market

Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market

  • $ 4995
  • Industry report
  • December 2016
  • by GBI Research

Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market Summary Cancer is a group of diseases characterized ...

Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016

Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016’, provides in depth analysis on Human ...

Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016

Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016

  • $ 2450
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight Report, “Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016” emphasizes on the currently active CAR-T cell products in ...

Mucin 1 (Breast Carcinoma Associated Antigen DF3 or Episialin or H23AG or Krebs Von Den Lungen 6 or PEMT or Peanut Reactive Urinary Mucin or Polymorphic Epithelial Mucin) - Pipeline Review, H2 2016

Mucin 1 (Breast Carcinoma Associated Antigen DF3 or Episialin or H23AG or Krebs Von Den Lungen 6 or PEMT or Peanut Reactive Urinary Mucin or Polymorphic Epithelial Mucin) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Mucin 1 (Breast Carcinoma Associated Antigen DF3 or Episialin or H23AG or Krebs Von Den Lungen 6 or PEMT or Peanut Reactive Urinary Mucin or Polymorphic Epithelial Mucin or Tumor Associated Epithelial ...

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H2 2016

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

About 5300 reports for Immunotherapy

Download Unlimited Documents from Trusted Public Sources

Car-T - Company Report, 2016

  • January 2016
    135 pages
  • Immunotherapy  

    Therapy  

    Cancer  

  • United States  

View report >

Annual Report, 2015

January 2015

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.